Novel prodrug compositions and utility of hydroxamate-based gcpii inhibitors
US-2019352255-A1 · Nov 21, 2019 · US
US10407534B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10407534-B2 |
| Application number | US-201615567513-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 15, 2016 |
| Priority date | Apr 23, 2015 |
| Publication date | Sep 10, 2019 |
| Grant date | Sep 10, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compounds of the formula in which R 1 is an organic radical having a (meth)acryloyl group and R 2 , R 3 , and R 4 independently of one another are an H atom or a C1 to C10 alkyl group.
Opening claim text (preview).
What is claimed is: 1. A compound of formula (I) in which R 1 is an organic radical having a (meth)acryloyl group and R 2 , R 3 , and R 4 independently of one another are an H atom or a C1 to C10 alkyl group. 2. The compound according to claim 1 , wherein R 1 is an organic radical having a total of not more than 24 C atoms and comprising no heteroatoms other than oxygen atoms. 3. The compound according to claim 1 , wherein R 1 is a group of formula (II) in which X is a bond or an alkylene group having 1 to 18 C atoms and R 5 is an H atom or a methyl group, or R 1 is a group of formula (III) in which m and p independently of one another are 0 or an integer from 1 to 10, R 5 is an H atom or a methyl group, and R 6 is an H atom or a C1 to C10 alkyl group, or R 1 is a group of formula (IV) in which s and t independently of one another are 0 or an integer from 1 to 10, R 5 is an H atom or a methyl group, and R 7 is an H atom or a C1 to C10 alkyl group. 4. The compound according to claim 1 , wherein R 2 is a methyl group and R 3 and R 4 are an H atom. 5. A process for preparing the compound of claim 3 , in which R 1 is a group of the formula (II), comprising: reacting, in a first stage, a compound having a terminal triple bond with a hydroxyalkanone or hydroxyalkanal, the triple bond undergoing addition to the carbonyl group of the hydroxyalkanone or hydroxyalkanal to form a dihydroxy compound, protecting, in a second stage, the hydroxyl group of the dihydroxy compound that did not originate from the carbonyl group with a protecting group, ring closing, in a third stage, to form a carbonate group with carbon dioxide, and replacing, in a fourth stage, the protecting group with a (meth)acryloyl group. 6. A process for preparing the compound of claim 3 , in which R 1 is a group of the formula (III), comprising: reacting, in a first stage, a compound having a terminal triple bond with an alkanone or alkanal which comprises an acetal group, the triple bond undergoing addition to the carbonyl group of the alkanone or alkanal to form a hydroxy compound, ring closing, in a second stage, to form a carbonate group with carbon dioxide, ring closing, in a third stage, to form a 1,3-dioxane ring by reaction of the acetal group with a compound having a total of at least three hydroxyl groups, with two of the hydroxyl groups being located in 1,3 position, and introducing, in a fourth stage, the (meth)acryloyl group by esterification or transesterification of the remaining hydroxyl group. 7. A process for preparing the compound of claim 3 , in which R 1 is a group of the formula (IV), comprising: reacting, in a first stage, a compound having a terminal triple bond with an alkanone or alkanal which comprises an acetal group, the triple bond undergoing addition to the carbonyl group of the alkanone or alkanal to form a hydroxy compound, ring closing, in a second stage, to form a carbonate group with carbon dioxide, ring closing, in a third stage, to form a 1,3-dioxolane ring by reaction of the acetal group with a compound having a total of at least three hydroxyl groups, with two of the hydroxyl groups being located in 1,2 position, and introducing, in a fourth stage, the (meth)acryloyl group by esterification or transesterification of the remaining hydroxyl group. 8. An epoxy resin composition comprising the compound of claim 1 . 9. An epoxy resin composition comprising a) a compound of claim 1 , b) an epoxy compound having at least one epoxy group c) optionally a hardener for the epoxy compound, and d) optionally a further constituent. 10. The epoxy resin composition according to claim 9 , comprising 0.1 to 10 000 parts by weight of the compound of the formula (I) per 100 parts by weight of the epoxy compound. 11. The epoxy resin composition according to claim 9 , wherein the hardener is present, and has at least one primary or secondary amino group. 12. A two-component binder system comprising: a component A comprising a) the compound of claim 1 , b) an epoxy compound having at least one epoxy group, and a component B comprising c) a hardener for the epoxy compound. 13. A coating material, casting material, or adhesive comprising the epoxy resin composition of claim 9 .
linked by a carbon chain containing only aliphatic carbon atoms · CPC title
containing an atom other than nitrogen belonging to the amine group, carbon and hydrogen · CPC title
Vinylene carbonate; Substituted vinylene carbonates · CPC title
aromatic · CPC title
cycloaliphatic · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.